Vimalan Biosciences is a startup based in the United States.
Based in the United States, Vimalan Biosciences is a startup.
Vimalan Biosciences develops selective Janus kinase (JAK) inhibitors for autoimmune and inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.